biospecimen_aliquot__bcr_aliquot_barcode	tcga-a2-a04r-01a-41d-a117-09
biospecimen_aliquot__bcr_aliquot_uuid	1f8e4326-dfc7-4635-a9b7-a9207a392748
biospecimen_aliquot__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
biospecimen_aliquot__bcr_sample_barcode	tcga-a2-a04r-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0100492221
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.07
biospecimen_aliquot__date_of_shipment	2011-01-18
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a117
biospecimen_aliquot__plate_row	a
biospecimen_aliquot__quantity	4.35
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	62.20
biospecimen_analyte__a260_a280_ratio	2.18
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-a2-a04r-01a-41d
biospecimen_analyte__bcr_analyte_uuid	103cdd0e-1e03-401d-ade3-eb2ea6dde0d7
biospecimen_analyte__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
biospecimen_analyte__bcr_sample_barcode	tcga-a2-a04r-01a
biospecimen_analyte__concentration	0.15
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a2-a04r
biospecimen_diagnostic_slides__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a2-a04r-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	be3661a3-a2a0-4248-b7d5-d8986e529b6c
biospecimen_normal_control__bcr_patient_barcode	tcga-a2-a04r
biospecimen_normal_control__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
biospecimen_normal_control__ncedna_dna_conc	0.382
biospecimen_normal_control__ncedna_dna_qm	spec (nanodrop)
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	52.4
biospecimen_portion__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
biospecimen_portion__bcr_portion_barcode	tcga-a2-a04r-01a-41
biospecimen_portion__bcr_portion_uuid	9dbbf121-e904-4a5b-b509-465b80f3407d
biospecimen_portion__bcr_sample_barcode	tcga-a2-a04r-01a
biospecimen_portion__date_of_creation	2010-06-09
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	41
biospecimen_portion__portion_sequence	4
biospecimen_portion__weight	20.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a2-a04r-01a-41d
biospecimen_protocol__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
biospecimen_protocol__bcr_sample_barcode	tcga-a2-a04r-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
biospecimen_sample__bcr_sample_barcode	tcga-a2-a04r-01a
biospecimen_sample__bcr_sample_uuid	e29fc4e1-4c82-46d7-997c-be59470c7751
biospecimen_sample__days_to_collection	2233
biospecimen_sample__initial_weight	160
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-a2-a04r.6a97c809-91bb-4e35-9e12-f5f2a58c9d35.pdf
biospecimen_sample__pathology_report_uuid	6a97c809-91bb-4e35-9e12-f5f2a58c9d35
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_slide__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
biospecimen_slide__bcr_sample_barcode	tcga-a2-a04r-01a
biospecimen_slide__bcr_slide_barcode	tcga-a2-a04r-01a-04-bsd
biospecimen_slide__bcr_slide_uuid	8ce73dd5-7124-4ff1-8a07-12b5e8aad3a9
biospecimen_slide__image_file_name	tcga-a2-a04r-01a-04-bsd.8ce73dd5-7124-4ff1-8a07-12b5e8aad3a9.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	1
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	4
biospecimen_slide__percent_stromal_cells	5
biospecimen_slide__percent_tumor_cells	90
biospecimen_slide__percent_tumor_nuclei	95
biospecimen_slide__section_location	bottom
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a2-a04r
biospecimen_tumor_sample__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
clinical_drug__bcr_drug_barcode	tcga-a2-a04r-d2555
clinical_drug__bcr_drug_uuid	59cf62c8-9052-43df-aefa-ea940996727a
clinical_drug__bcr_patient_barcode	tcga-a2-a04r
clinical_drug__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
clinical_drug__form_completion_date	2010-10-12
clinical_drug__pharmaceutical_therapy_drug_name	tamoxifen
clinical_drug__pharmaceutical_therapy_type	hormone therapy
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ended_days_to	909
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	399
clinical_drug__prescribed_dose	20
clinical_drug__regimen_number	4
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-a2-a04r-f59315
clinical_follow_up__bcr_followup_uuid	c91d9225-7ad4-4f0c-9851-d37807aa970a
clinical_follow_up__bcr_patient_barcode	tcga-a2-a04r
clinical_follow_up__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2014-5-8
clinical_follow_up__last_contact_days_to	3709
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	36
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0 (i-)
clinical_patient__ajcc_pathologic_tumor_stage	stage ia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t1
clinical_patient__anatomic_neoplasm_subdivision	left upper inner quadrant
clinical_patient__axillary_staging_method	sentinel node biopsy alone
clinical_patient__bcr_patient_barcode	tcga-a2-a04r
clinical_patient__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
clinical_patient__birth_days_to	-13483
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__er_status_ihc_Percent_Positive	60-69%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2010-10-8
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.1
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2004
clinical_patient__last_contact_days_to	2365
clinical_patient__lymph_nodes_examined_count	1
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__lymph_nodes_examined_ihc_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	yes
clinical_patient__patient_id	a04r
clinical_patient__pr_status_by_ihc	positive
clinical_patient__pr_status_ihc_percent_positive	80-89%
clinical_patient__prospective_collection	no
clinical_patient__race	black or african american
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	lumpectomy
clinical_patient__tissue_source_site	a2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-a2-a04r
clinical_radiation__bcr_patient_uuid	f3a058b9-fb7f-4098-8f0e-83c2acfa1ed5
clinical_radiation__bcr_radiation_barcode	tcga-a2-a04r-r2557
clinical_radiation__bcr_radiation_uuid	7b76f4d4-65c9-4ff3-abef-09844e8fc56a
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2010-10-12
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	342
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	300
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A04R-01A-41D-A117-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A04R-01A-41D-A117-09.bed.meta
manually_curated__id	tcga-a2-a04r-01a-41d-a117-09
manually_curated__md5sum	1d7feb1ebd1c12c5c4865b61e424ea75
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	1f8e4326-dfc7-4635-a9b7-a9207a392748
manually_curated__tumor_tag	brca
